Ontology highlight
ABSTRACT: Background
Triphala is an indigenous medical product used for a variety of diseases. This study was conducted to determine the effect of Triphala on antibiotic properties of gentamicin and oxacillin against multi-drug resistant organisms.Methods
The checkerboard method was used to determine the synergy of Triphala with gentamicin and oxacillin against multi-drug resistant (MDR) Gram negative bacilli and methicillin-resistant Staphylococcus aureus (MRSA) using 2,3,5-triphenyltetrazolium chloride (TTC) assay. Fractional inhibitory concentration (FIC) index was calculated.Results
When tested alone, the minimum inhibitory concentration (MIC) values of gentamicin for Gram negative isolates ranged from 8 to >?64??g/ml. The MIC values of gentamicin for the Gram negative isolates ranged from 1 to 32??g/ml when tested with Triphala. The FIC index was ?16??g/ml with all MICs being equal to or higher than the resistance cut-off level. The MIC level with the addition of Triphala ranged from 0.25 to 4??g/ml. FIC index was ConclusionsTriphala has synergistic activity with gentamicin against the selected MDR Gram negative bacilli and with oxacillin against MRSA isolates warranting further studies on the possibility of clinical use.
SUBMITTER: Manoraj A
PROVIDER: S-EPMC6679468 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
Manoraj Amirthasingam A Thevanesam Vasanthi V Bandara B M R BMR Ekanayake Asela A Liyanapathirana Veranja V
BMC complementary and alternative medicine 20190802 1
<h4>Background</h4>Triphala is an indigenous medical product used for a variety of diseases. This study was conducted to determine the effect of Triphala on antibiotic properties of gentamicin and oxacillin against multi-drug resistant organisms.<h4>Methods</h4>The checkerboard method was used to determine the synergy of Triphala with gentamicin and oxacillin against multi-drug resistant (MDR) Gram negative bacilli and methicillin-resistant Staphylococcus aureus (MRSA) using 2,3,5-triphenyltetra ...[more]